Physician profile
Daniel J Wunder
NPI 1457306565
$1,923.70
in general payments reported to CMS, 2019-2025
14 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $146 · 2021: $140 · 2022: $109 · 2023: $313 · 2024: $234 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $795.18 | 2022-2025 | Evenity, Prolia, Prolia |
| Radius Health, INC. | $350.52 | 2019-2025 | Tymlos |
| Medtronic Vascular, INC. | $197.02 | 2019-2020 | |
| Cook Medical LLC | $156.98 | 2019-2023 | Cook Celect |
| Teleflex LLC | $112.02 | 2019-2025 | Arrow |
| Boston Scientific Corporation | $73.54 | 2019 | |
| Bard Peripheral Vascular, INC. | $59.27 | 2020 | |
| Globus Medical, INC. | $36.05 | 2025 | Senza |
| Abbott Laboratories | $30.68 | 2021 | |
| Terumo Medical Corporation | $29.51 | 2019 | |
| W. L. Gore & Associates, INC. | $27.49 | 2023 | Gore Cardioform Septal Occluder |
| Angiodynamics, INC. | $22.07 | 2022 | |
| Medtronic, INC. | $18.60 | 2023 | Hawkone |
| Blue Earth Diagnostics | $14.77 | 2025 | Posluma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wunder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.